New Jersey has enacted its Fiscal Year 2027 budget, with the Legislature passing a $60.7 billion spending plan ahead of the June 30 constitutional deadline. The budget maintains Governor Mikie Sherrill's proposed spending level, reduces the state's structural deficit by roughly half, preserves a Continue Reading
Chancery Clarifies Limits of Personal Jurisdiction: Choice-of-Law Clauses, Director Appointments, and Hypothetical Delaware Filings Are Not Enough
In Zync, Inc. v. Porsche Investments Management, S.A., et al., C.A. No. 2025-0284-JTL, the Delaware Court of Chancery dismissed defendant Ulrich Thiem for lack of personal jurisdiction after concluding that the alleged Delaware contacts did not satisfy either Delaware’s long-arm statute or its Continue Reading
Appellate Court Raises the Bar for Patent Owners Pursuing Estoppel, Once Again
As a defense to accusations of patent infringement, accused infringers sometimes file inter partes reviews (IPRs) in the US Patent Office. IPRs allow one to challenge the validity of a patent as anticipated or obvious in view of the prior art. The risk, however, is that if the challenger Continue Reading
USPTO Institutes Stricter Requirements for “Unintentional Delay” Petitions
Today, the U.S. Patent and Trademark Office (USPTO) published a notice in the Federal Register, shortening the grace period for “unintentionally delayed” patent petitions from two years to one year before requiring a detailed justification and an additional fee. What You Need to Continue Reading
Here Comes the Boom: SBA Proposes New 8(a) “Social Disadvantage” Test
On June 11, 2026, the Small Business Administration (SBA) issued a much-anticipated proposed rule aimed at overhauling the 8(a) Business Development Program. More specifically, the proposed rule, entitled “Reforms To Remove SBA’s 8(a) Program’s Rebuttable Presumption of Social Disadvantage” and Continue Reading
Undefined Experimental Parameters May Lead to Limited Claim Scope
Failure to define the parameters governing numerical values for claim limitations, such as pH, can result in undesired outcomes in litigation. In some cases, claim terms relating to measured parameters have been found to be indefinite and therefore invalid. But even when the scope of the claim terms Continue Reading
Trim the Claims and the Budget: USPTO Waives Petition Fee for Pilot Program
The Patent Office has made the Streamlined Claim Set Pilot Program a little easier to use by waiving the $150 petition fee ($60 for Small Entity) that would otherwise apply. This program offers an attractive alternative to the much more costly Track One filing for patent applications. In practical Continue Reading
New Jersey 2025 Regulatory Updates: Part 3
Part 3 of our 2025 New Jersey Regulatory Update highlights additional recently adopted rules and amendments impacting healthcare providers, long-term care facilities, residential operators, and licensed professionals. These updates span a range of operational, licensure, compliance, and resident Continue Reading
What We Do in the Shadows…with Shadow AI: The Growing Business Risk of Unauthorized Artificial Intelligence Tools
Many of today’s employers are eager to reap the benefits of emerging artificial intelligence-powered tools and are pressing their teams to identify and implement ways in which AI can improve their work. Some of these employers are approaching the AI revolution with business risks in mind, carefully Continue Reading
No “Skinny Dipping” into Liability: SCOTUS Delivers Win for Generic Drugs
The manufacture and distribution of generic pharmaceutical drugs is a polarizing topic in the political and legal world. The manufacturing and marketing of generic versions of brand-name drugs are allowed in the United States if (1) the generic company obtains approval from the Food and Drug Continue Reading